Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Safety Study in Patients With Chronic Lymphocytic Leukemia

This study has been completed.
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by:
Seattle Genetics, Inc.
ClinicalTrials.gov Identifier:
NCT00283101
First received: January 25, 2006
Last updated: December 17, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2006
  Primary Completion Date: October 2006 (Final data collection date for primary outcome measure)
Publications: